Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

NACompletedINTERVENTIONAL
Enrollment

495

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT
Interventions
OTHER

Individualized Survivorship Care Plan (SCP)

The individualized SCP incorporates patient specific treatment exposures and provides a framework for long term followup based on those exposures and subsequent risks for late complications.

Trial Locations (17)

14263

Roswell Park Cancer Institute, Buffalo

19104

University of Pennsylvania, Philadelphia

27599

UNC Chapel Hill, Chapel Hill

32608

University of Florida, Shands Hospital, Gainesville

37232

Vanderbilt-Ingram Cancer Center, Nashville

43210

Ohio State University, Columbus

44106

University Hospitals Case Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

48201

Karmanos Cancer Institute, Detroit

55455

University of Minnesota Medical Center, Minneapolis

55905

Mayo Clinic Rochester, Rochester

60153

Loyola Medical Center, Maywood

66205

University of Kansas Cancer Center, Westwood

75246

Baylor University Medical Center, Dallas

98109

Fred Hutchinson Cancer Research Center, Seattle

85259-5499

Mayo Clinic, Scottsdale

01655

University of Massachusetts Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

National Marrow Donor Program

OTHER

lead

Center for International Blood and Marrow Transplant Research

NETWORK

NCT02200133 - Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors | Biotech Hunter | Biotech Hunter